Hyloris Pharmaceuticals SA (EBR:HYL)
Belgium flag Belgium · Delayed Price · Currency is EUR
3.720
-0.230 (-5.82%)
Oct 9, 2026, 5:07 PM CET

Hyloris Pharmaceuticals Cash Flow Statement

Millions EUR. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-4.65-6.33-6.34-15.38-11.91-11.58
Depreciation & Amortization
0.520.440.450.380.150.11
Other Amortization
0.280.280.19-0.120.08-
Loss (Gain) From Sale of Assets
----0.02-
Asset Writedown & Restructuring Costs
0.640.2-0.09-0.02
Loss (Gain) From Sale of Investments
-0.97-0.970.97---
Loss (Gain) on Equity Investments
0.180.070.080.150.130.19
Stock-Based Compensation
0.710.67-0.580.540.560.58
Other Operating Activities
-0.42-0.64-0.2-0.7-0.060.2
Change in Accounts Receivable
-2.59-0.27-2.310.03-0.92-2.07
Change in Inventory
0.08-0.05----
Change in Accounts Payable
-1.61-0.440.141.05-0.47-
Change in Other Net Operating Assets
0.110.070.41.16-0.591.29
Operating Cash Flow
-7.75-6.99-7.19-12.81-13.02-11.25
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.08-0-0.03-0.3-0.1-0.11
Sale (Purchase) of Intangibles
-1.16-0.63-0.27-0.45-0.64-0.74
Investment in Securities
-0.5-1.9-10-10.5-2.23
Other Investing Activities
0.210.40.980.640.52-0
Investing Cash Flow
-1.53-2.130.689.89-11.37-3.08

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
--0.140.05--
Total Debt Issued
0.11-0.140.05--
Long-Term Debt Repaid
--0.34-0.48-0.17-7.46-0.06
Lease Payments
-0.36-0.34-0.26-0.17-0.08-
Net Debt Issued (Repaid)
-0.25-0.34-0.34-0.12-7.46-0.06
Issuance of Common Stock
----17.17-
Other Financing Activities
-0.07-0.07-0.08-0.01-1.88-
Financing Cash Flow
-0.31-0.41-0.42-0.137.84-0.06

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.29-0.30.12---
Miscellaneous Cash Flow Adjustments
----0--
Net Cash Flow
-9.88-9.82-6.81-3.05-16.56-14.39

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-7.83-6.99-7.22-13.11-13.12-11.36
Free Cash Flow Growth
------
Free Cash Flow Margin
-79.69%-88.08%-74.00%-348.66%-549.69%-366.83%
Free Cash Flow Per Share
-0.28-0.25-0.26-0.47-0.48-0.44
Levered Free Cash Flow
-8.8-6.51-5.16-8.03-10.4-3.54
Unlevered Free Cash Flow
-8.76-6.47-5.11-8-10.27-3.2
Free Cash Flow After Leases
-8.19-7.33-7.49-13.28-13.2-11.36

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
0.060.070.080.061.88-
Cash Income Tax Paid
----0.35-
Change in Working Capital
-4.01-0.69-1.772.23-1.98-0.78